Cargando…
Targeting Glioblastoma: The Current State of Different Therapeutic Approaches
BACKGROUND: Glioma is the primary cancer of the central nervous system in adults. Among gliomas, glioblastoma is the most deadly and aggressive form, with an average life span of 1 to 2 years. Despite implementing the rigorous standard care involving maximal surgical removal followed by concomitant...
Autores principales: | Khan, Imran, Mahfooz, Sadaf, Elbasan, Elif Burce, Karacam, Busra, Oztanir, Mustafa Namik, Hatiboglu, Mustafa Aziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977637/ https://www.ncbi.nlm.nih.gov/pubmed/33441071 http://dx.doi.org/10.2174/1570159X19666210113152108 |
Ejemplares similares
-
Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma
por: Khan, Imran, et al.
Publicado: (2021) -
Glioma cancer stem cells modulating the local tumor immune environment
por: Khan, Imran, et al.
Publicado: (2022) -
Identification of Genetic Alterations in Rapid Progressive Glioblastoma by Use of Whole Exome Sequencing
por: Khan, Imran, et al.
Publicado: (2023) -
Can COVID-19 induce glioma tumorogenesis through binding cell receptors?
por: Khan, Imran, et al.
Publicado: (2020) -
What is the effectiveness of beta-glucan for treatment of acute otitis media?
por: Cetinkaya, Erdem Atalay, et al.
Publicado: (2020)